Abstract:Objective: The accurate detection of phospholipase A2 receptor (PLA2R) autoantibody is crucial in the diagnosis and monitoring of primary membranous nephropathy (pMN). While enzyme-linked immunosorbent assay (ELISA) is the commonly used detection method, its complexity and timeconsuming nature pose challenges, especially for small sample sizes. Chemiluminescence immunoassay (CLIA) has emerged as a rapid alternative for clinical immunoassays. This study aims to compare the sensitivity, specificity, and precision of CLIA and ELISA in detecting PLA2R autoantibody. Method: A total of 145 patients with biopsy-confirmed primary membranous nephropathy and 85 patients with non-membranous nephropathy were enrolled in this comparative study. CLIA and ELISA were employed to test all samples for the presence of PLA2R autoantibodies. Statistical analysis of sensitivity, specificity, accuracy, positive predictive value (PPV), and negative predictive value (NPV) was performed using SPSS 26.0. The diagnostic value of ELISA and CLIA for pMN was analyzed using the ROC curve, and Correlation analysis was performed using Spearman. Results: Serum levels of anti-PLA2R antibody in pMN group were significantly higher than those in nMN group(P < 0.05). The accuracy of CLIA for detecting anti-PLA2R antibody was 76.96%, while ELISA showed an accuracy of 74.78%. The sensitivity for CLIA was 64.83%, compared to 60% for ELISA. However, no statistically significant difference was observed between the two methods (P > 0.05). The overall qualitative agreement of anti-PLA2R detection was 93.35% (95% confidence interval[CI] 89.47-96.3). ROC curve analysis showed that AUC of anti-PLA2R antibody detected by ELISA and CLIA were 0.8737 (95% confidence interval [CI] 0.8270-0.9204), 0.8914 (95% confidence interval [CI]0.8495-0.9332), respectively. The Spearman correlation analysis revealed a significant correlation between them(P < 0.05). Notably, CLIA demonstrated a significant time-saving advantage, particularly when the sample size was less than 200, and especially when it was less than 20. Conclusion: CLIA and ELISA showed similar accuracy and consistency in detecting anti-PLA2R antibody for primary membranous nephropathy. However, CLIA exhibited a significant advantage in terms of automation and time -saving compared to ELISA, particularly for smaller sample sizes. This finding suggests that CLIA has the potential to become a preferred and widely adopted test in the future.

M-Type Phospholipase A2 Receptor Autoantibody Measured by ELISA has Diagnostic Value in Patients with Idiopathic Membranous Nephropathy

Urine PLA2R Antibody Detection in Hazard Stratification of PLA2R-Associated Membranous Nephropathy.

Diagnostic value of serum PLA2R antibody detection for idiopathic membranous nephropathy: A meta-analysis

A Novel Time-Resolved Fluoroimmunoassay Based on Magnetic Microspheres Method for Detecting Antibodies Against the Phospholipase A2 Receptor.

Quantitative Detection of Anti-Pla2r Antibodies Targeting Different Epitopes and Its Clinical Application in Primary Membranous Nephropathy.

Serum Antibody and Glomerular Antigen of Antiphospholipase A2 Receptor in Chinese Patients with Idiopathic Membranous Nephropathy

[Diagnostic Value of Renal Phospholipase A2 Receptor and Serum Anti-Phospholipase A2 Receptor Antibody in Membranous Nephropathy].

Ultrasensitive Quantitation of Anti-Phospholipase A2 Receptor Antibody As A Diagnostic and Prognostic Indicator of Idiopathic Membranous Nephropathy

Anti-phospholipase A2 Receptor Antibody in Membranous Nephropathy.

Serum Phospholipase A2 Receptor Antibodies and Immunoglobulin G Subtypes in Adult Idiopathic Membranous Nephropathy: Clinical Value Assessment.

Diagnostic Efficacy of Serum Anti-Phospholipase A2 Receptor Antibodies for Idiopathic Membranous Nephropathy in Patients with Diabetic Kidney Disease.

The Application of Podocyte Antigen PLA2R and Anti-Pla2r Antibody in the Diagnosis and Treatment of Membranous Nephropathy

Progress on the M-type Phospholipase A2 Receptor in Idiopathic Membranous Nephropathy

Diagnostic Test Accuracy of Serum Anti-PLA2R Autoantibodies and Glomerular PLA2R Antigen for Diagnosing Idiopathic Membranous Nephropathy: an Updated Meta-Analysis

Serum Anti-PLA2R Antibody Predicts Treatment Outcome in Idiopathic Membranous Nephropathy

The significance of anti-PLA2R antibody for the diagnosis and treatment of idiopathic membranous nephropathy

Detection And Clinical Significance Of Glomerular M-Type Phospholipase A(2) Receptor In Patients With Idiopathic Membranous Nephropathy

Establishment and application of an immunoassay for the simultaneous detection of IgG and its subtype IgG4 autoantibodies against M-type phospholipase A2 receptor

A Comparison of Chemiluminescent Immunoassay and Enzyme-Linked Immunosorbent Assay for Detecting Phospholipase A2 Receptor Antibody in Primary Membranous Nephropathy

Detection of PLA2R1 in Renal Biopsy Specimens of Patients with Idiopathic Membranous Ne-Phropathy

The Cutoff Value and Prognosis of Anti-Pla2r Antibody for Idiopathic Membranous Nephropathy: a Single-Center Retrospective Study in China.